Heart disease patient risk classification based on neutrosophic sets
by Wael K. Hanna; Nouran M. Radwan
International Journal of Business Intelligence and Data Mining (IJBIDM), Vol. 20, No. 1, 2022

Abstract: Medical statistics show that heart disease is one of the biggest causes for mortality among the population. In developing countries, people have less concern about their health. The risk is increasing as 500 deaths per 100,000 occur annually in Egypt. The diagnosis of heart disease remains an ambiguous task in the medical field as there are many features involved in order to take the decision. Besides, data gained for diagnosis are often vague and ambiguous. The main contribution of this paper is proposing a novel model of heart disease patient risk classification based on neutrosophic sets. The proposed model is applied to most relevant attributes of selected dataset, and compared to other famous classification techniques such as naive Bayesian, JRip, and random forest for validation. The experimental results indicate that the proposed heart disease classification model achieves highest accuracy and F-measure results in heart disease classification.

Online publication date: Tue, 04-Jan-2022

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Intelligence and Data Mining (IJBIDM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com